• Explore /
  • Poster
  • / Apalutamide toxicity and tolerability: A real-world multicentre experience in metastatic hormone-sensitive prostate cancer (MHSPC) in the United Kingdom (UK).

Apalutamide toxicity and tolerability: A real-world multicentre experience in metastatic hormone-sensitive prostate cancer (MHSPC) in the United Kingdom (UK).

Abstract Poster

Authors

null

Sindhu Ramamurthy

United Lincolnshire Hospitals NHS Trust, Lincoln, United Kingdom

Sindhu Ramamurthy , Thiraviyam Elumalai , Rachel Pearson , Iakov Bolnykh , Tehreem Muhammad-Afzal , Gbenro Olukiran , Ananya Arora , Gay Bradley , Kate Taft , Nayan Lin Myint , Ei The Htike , Will Ince , Xue Yan Jiang

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer - Advanced,Prostate Cancer - Localized

Sub Track

Symptoms, Toxicities, Patient-Reported Outcomes, and Whole-Person Care

Citation

J Clin Oncol 42, 2024 (suppl 4; abstr 107)

DOI

10.1200/JCO.2024.42.4_suppl.107

Abstract #

107

Poster Bd #

D22

Abstract Disclosures

Similar Posters

First Author: Prantik Das

First Author: Soumyajit Roy

First Author: Gordon Andrew Brown

First Author: Giulio Francolini